Preferred Label : Solifenacin Succinate;
MeSH definition : A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST.
It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.;
MeSH synonym : Succinate, Solifenacin; Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate;
MeSH Hyperonym : solifenacin; 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1- azabicyclo(2.2.2)oct-3-yl
ester, (R-(R*,S*))-;
MeSH hyponym : YM905; vesicare; YM 905; 905, YM;
MeSH Related Number : 242478-38-2; A8910SQJ1U;
Wikipedia link : https://en.wikipedia.org/wiki/Solifenacin;
Is substance : O;
UNII : KKA5DLD701;
Origin ID : D000069464;
UMLS CUI : C1509436;
ATC code(s)
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST.
It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.
https://www.has-sante.fr/jcms/p_3476380/fr/vecalmys-succinate-de-solifenacine-/-chlorhydrate-de-tamsulosine-troubles-urologiques
2023
false
false
false
France
administration, oral
drug combinations
treatment outcome
insurance, health, reimbursement
tamsulosin and solifenacin
urinary incontinence, urge
Urinary Frequency
Enlarged Prostate with Lower Urinary Tract Symptoms
prostatic hyperplasia
urological agents
evaluation of the transparency committee
tamsulosin hydrochloride
Tamsulosin
Solifenacin Succinate
---
https://www.has-sante.fr/portail/jcms/c_2884952/fr/vesicare
https://www.has-sante.fr/portail/jcms/c_2884952/fr/vesicare-suspension-buvable-solifenacine-antagoniste-des-recepteurs-cholinergiques
2018
false
false
false
France
Solifenacin Succinate
administration, oral
treatment outcome
insurance, health, reimbursement
urinary incontinence
child
adolescent
urinary bladder, overactive
adult
solifenacin
guidelines for drug use
muscarinic antagonists
overactive detrusor
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_2606651/fr/vesicare
http://www.has-sante.fr/portail/jcms/c_1622366/fr/vesicare
http://www.has-sante.fr/portail/jcms/c_866780/fr/vesicare
http://www.has-sante.fr/portail/jcms/c_400955/fr/vesicare
2016
false
France
French
evaluation of the transparency committee
Solifenacin Succinate
administration, oral
solifenacin
muscarinic antagonists
urinary incontinence
adult
aged
treatment outcome
insurance, health, reimbursement
urinary bladder, overactive
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-02/fiche_bon_usage_vesicare.pdf
https://www.has-sante.fr/jcms/r_1439701
2010
true
France
French
Solifenacin Succinate
urinary frequency
administration, oral
solifenacin
muscarinic antagonists
urinary incontinence, urge
urinary incontinence
treatment outcome
adult
aged
guidelines for drug use
---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Vesicare-Resubmisson_1_June-17-2009-%20fr.pdf
2009
false
Canada
French
Solifenacin Succinate
muscarinic antagonists
urinary bladder, overactive
solifenacin
drug evaluation
---
http://www.has-sante.fr/portail/jcms/c_928091/vesicare-solifenacine-anticholinergique
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-10/vesicare_-_ct-6967.pdf
2009
false
France
French
guidelines for drug use
Solifenacin Succinate
Solifenacin Succinate
evaluation of the transparency committee
cholinergic antagonists
administration, oral
solifenacin
insurance, health, reimbursement
urinary incontinence
adult
aged
treatment outcome
cholinergic antagonists
---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Vesicare_Jan-24-2007_f.pdf
2007
false
Canada
French
Solifenacin Succinate
urinary bladder, overactive
muscarinic antagonists
solifenacin
drug evaluation
---